Defining Targets And Establishing Methods For Prevention, Diagnosis And Therapy Of Inflammation, Atherosclerosis And Thrombosis
Funder
National Health and Medical Research Council
Funding Amount
$847,490.00
Summary
My research focuses on preventing and treating atherosclerotic disease and its complications such as heart attack and stroke. This will be achieved by developing new imaging technologies, with the aim to detect unstable atherosclerotic plaques, as well as innovative new drugs preventing inflammation and thrombosis as the major contributors of heart attack and stroke.
Research Fellowship: Protection Of Myocardial Function In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$631,010.00
Summary
Heart failure (HF) is a major cause of death in Australia. A/Prof Rebecca Ritchie heads Heart Failure Pharmacology at Baker IDI. Her research focuses on new drug strategies to maintain heart function in response to diabetes & heart attack, common precursors of HF. Many of the treatments discovered from this work are naturally-occurring antioxidants; enhancing their activity will ultimately reduce progression to HF & death in the >3 million Australians affected by these disorders.